Ministry of Health and Family Welfare Gazette Notification — 2023-01-20

Executive Summary & Key Takeaways

The gazette notification provides the tentative schedule for the Subject Expert Committee (SEC) meetings related to vaccines for the year 2023.
The schedule lists the month and tentative date for each meeting, along with the corresponding day of the week.
It also includes a note indicating that additional meetings may be planned based on requirements.

The notification outlines the tentative dates for the SEC (Vaccine) meetings for each month of 2023.
January meeting is scheduled for 23.01.2023 (Monday).
February meeting is scheduled for 22.02.2023 (Wednesday).
March meeting is scheduled for 23.03.2023 (Thursday).
April meeting is scheduled for 25.04.2023 (Tuesday).
May meeting is scheduled for 18.05.2023 (Thursday).
June meeting is scheduled for 26.06.2023 (Monday).
July meeting is scheduled for 18.07.2023 (Tuesday).
August meeting is scheduled for 23.08.2023 (Wednesday).
September meeting is scheduled for 12.09.2023 (Tuesday).
October meeting is scheduled for 31.10.2023 (Tuesday).
November meeting is scheduled for 22.11.2023 (Wednesday).
December meeting is scheduled for 14.12.2023 (Thursday).
The schedule is tentative and subject to change, with additional meetings possible based on requirements.

Action Items: Review the schedule and prepare relevant data and presentations for the meetings. Monitor for any updates or changes to the schedule. Be prepared for ad-hoc meetings.

Action Items: Stay informed about the SEC's decisions and recommendations regarding vaccines. Adjust vaccination strategies based on new approvals or guidelines.

Action Items: Ensure adequate resources are available to support the SEC meetings and implement any recommendations or decisions arising from them. Communicate updates to relevant stakeholders.

Action Items: Stay informed about vaccine recommendations from trusted sources and consult with healthcare providers regarding vaccination decisions.

SEC (Vaccine): Subject Expert Committee responsible for reviewing and evaluating data related to vaccines.